TGF-β/Smads信号通路在干细胞移植治疗化疗损伤性卵巢早衰中的分子机制

基本信息
批准号:81360095
项目类别:地区科学基金项目
资助金额:48.00
负责人:徐仙
学科分类:
依托单位:宁夏医科大学
批准年份:2013
结题年份:2017
起止时间:2014-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:李永丽,杨延周,刘春莲,马小红,马晓娜,陈琰,马丽丽,张永芳
关键词:
间充质干细胞干细胞移植TGFβ/Smads信号通路化疗损伤卵巢早衰
结项摘要

It was noticed that young women who have been diagnosed as tumor and treated with the chemotherapy would result in the suppression of some specific signaling pathways. This could induce the premature ovarian failure (POF) which would perform as infertility and decreased life quality. Reactivating these signaling pathways could help rebuild the normal ovarian function. Previous research have shown that the cytokines secreted by the mesenchymal stem cells played crucial role on the microenvironment of follicle development. In this study, rats performed as POF which induced by the alkylating agent would be used as the animal models. Littermates treated with the estradiol valerate would be taken as the controls. The transplantation of the human placenta-derived mesenchymal stem cells and the rat marrow mesenchymal stem cells would be conducted for both groups. The expression of TGF-β/Smads signaling pathway and ovary related genes or proteins, the targetted position of stem cells, the serum hormone levels before and after the trasplantation would be measured with the real-time polymerase chain reaction,the high resolution melting method,the immunohistochemistry,Western blot,the laser confocal and intravital imaging techniques, respectively. Molecules of the TGF-β/Smads signaling pathway which have close correlation for the repairment of ovarian function and the modification of genetic epigenetic inheritance would be studied. The fertility of both groups after the transplantation would be measured as mating with the male littermates. This study would yield novel information on the improvement of ovarian dysfunction and the retrieving of female fertility by detecting mechanisms of the stem cell transplantation therapy for POF.

年轻女性因肿瘤接受化疗导致卵巢内特定的信号被抑制,可不同程度地出现卵巢早衰(POF)并致不孕,严重影响她们的生活质量,因此激活此信号通路有可能恢复卵巢功能。有研究显示移植的间充质干细胞旁分泌的细胞因子和生长因子能够改善卵泡生长微环境。本项目针对烷化剂所致POF大鼠模型,以戊酸雌二醇治疗POF为对照,采用大鼠骨髓间充质干细胞和人源胎盘间充质干细胞移植治疗化疗损伤性POF,应用Real-time PCR、高分辨率熔解曲线法、免疫组化、Western blot、激光共聚焦及活体成像技术研究干细胞移植前后与TGF-β/Smads通路相关和大鼠卵巢功能相关的基因、蛋白的表达、干细胞定位、内分泌功能,明确干细胞移植前后基因的表观遗传修饰及通路中相关因子在修复POF中的作用,并与雄鼠合笼评估其生殖能力,探讨化疗损伤后干细胞移植治疗POF的分子机制,为POF患者改善卵巢功能和恢复生育能力提供科学依据。

项目摘要

目的: 探讨化疗药物环磷酰胺(CTX)致大鼠卵巢早衰(POF)模型的血清生殖激素水平、卵巢细胞凋亡和间质损伤等特征;移植鼠源骨髓间充质干细胞 (BMSCs)移植对卵巢中转化生长因子β受体Ⅱ (TGF-βRⅡ) 表达的影响;人胎盘间充质干细胞(hPMSCs)移植治疗对环磷酰胺所致卵巢早衰模型(POF)SD大鼠后超氧化物歧化酶(SOD1)和解耦联蛋白2(UCP-2)表达的影响。.方法:以10周龄雌性SD大鼠为研究对象,以50mg•kg-1的首剂量腹腔注射环磷酰胺,再以8mg•kg-1连续腹腔注射14d,建立POF模型。将正常动情周期的SD雌性大鼠48只随机分为对照组、模型组 (环磷酰胺致POF) 、造模后自然恢复组和BMSCs移植组 (尾静脉移植) 和hPMSC移植组。分别于建模后、BMSCs移植后取各组卵巢组织, VG染色和HE染色, 光镜下观察卵巢组织形态和计数各组卵泡数。免疫组织化学法和Western blot检测各组卵巢组织TGF-βRⅡ及SOD1和UCP-2蛋白表达的情况。.结果:CTX致大鼠模型的血清生殖激素异常,卵巢间质纤维化,颗粒细胞凋亡,大鼠卵巢功能过早衰竭。BMSCs移植可改善由化疗导致卵巢早衰的功能部分恢复, TGF-βRⅡ可能参与了移植BMSCs修复化疗后POF的过程。hPMSC移植改善卵巢早衰SD大鼠氧化应激和SOD1及UCP-2表达,起到保护卵巢线粒体功能的作用。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
2

坚果破壳取仁与包装生产线控制系统设计

坚果破壳取仁与包装生产线控制系统设计

DOI:10.19554/j.cnki.1001-3563.2018.21.004
发表时间:2018
3

基于分形维数和支持向量机的串联电弧故障诊断方法

基于分形维数和支持向量机的串联电弧故障诊断方法

DOI:
发表时间:2016
4

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

DOI:10.3389
发表时间:2021
5

Himawari-8/AHI红外光谱资料降水信号识别与反演初步应用研究

Himawari-8/AHI红外光谱资料降水信号识别与反演初步应用研究

DOI:
发表时间:2020

徐仙的其他基金

批准号:81560261
批准年份:2015
资助金额:38.00
项目类别:地区科学基金项目

相似国自然基金

1

经血子宫内膜间充质干细胞移植协同补肾调冲方治疗化疗损伤性卵巢早衰的实验研究

批准号:81303108
批准年份:2013
负责人:杜雪
学科分类:H3302
资助金额:23.00
项目类别:青年科学基金项目
2

基于PI3K/AKT信号通路探讨二仙汤治疗化疗损伤性卵巢早衰的作用机理

批准号:81273887
批准年份:2012
负责人:牛建昭
学科分类:H3301
资助金额:70.00
项目类别:面上项目
3

TGF-β1/Smads信号通路在化疗诱导CD133+肝癌干细胞富集和耐药的机制研究

批准号:81172285
批准年份:2011
负责人:吴国洋
学科分类:H1814
资助金额:55.00
项目类别:面上项目
4

补肾养阴法调节PI3K/AKT信号通路促进干细胞治疗化疗后卵巢早衰的机制研究

批准号:81373805
批准年份:2013
负责人:秦佳佳
学科分类:H3302
资助金额:70.00
项目类别:面上项目